Evidence map›Paper›PMID 30533050›Full record

ArticlePloS one2018

A multicentre study investigating parameters which influence direct bacterial identification from urine.

Yuliya Zboromyrska, Jordi Bosch, Jesus Aramburu, Juan Cuadros, Carlos García-Riestra, Julia Guzmán-Puche, Carmen Liébana Martos, Elena Loza, María Muñoz-Algarra, Carlos Ruiz de Alegría and 2 more

Open access · goldAbstract readMulticenter Study
In one paragraph

Article in PloS one, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
0.8field-weighted citation impact, top 29% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 12 citations in OpenAlex.

  1. Clinical application of MALDI-TOF MS for direct and rapid pathogen identification: a comprehensive review focusing on bloodstream infections and sterile body fluids.European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology · 2026
    Review
  2. Article
  3. Article
  4. Article
  5. Review
  6. Review
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 10 institutions in 1 country.

Yuliya ZboromyrskaConsorci del Laboratori Intercomarcal, Vilafranca del Penedès, Spain.ORCID 0000-0003-2716-4729
Jordi BoschDepartment of Clinical Microbiology, Hospital Clínic, School of Medicine, University of Barcelona, Barcelona, Spain.
Jesus AramburuMicrobiology Unit, Hospital Universitari Arnau de Vilanova, Lleida, Spain.
Juan CuadrosMicrobiology Department, Hospital Príncipe de Asturias, Alcalá de Henares, Spain.
Carlos García-RiestraMicrobiology Department, Complejo Hospitalario Universitario de Santiago de Compostela, Santiago de Compostela, Spain.
Julia Guzmán-PucheMicrobiology Unit, Hospital Reina Sofía, IMIBIC-Reina Sofía University Hospital-University of Córdoba, Córdoba, Spain.
Carmen Liébana MartosInfectious Diseases and Clinical Microbiology Unit, Complejo Hospitalario de Jaén, Jaén, Spain.ORCID 0000-0002-3671-1539
Elena LozaDepartment of Microbiology, Hospital Universitario Ramón y Cajal, Madrid, Spain.
María Muñoz-AlgarraDepartment of Clinical Microbiology, Hospital Universitario Puerta de Hierro, Majadahonda, Spain.
Carlos Ruiz de AlegríaMicrobiology Department, Hospital Universitario Marqués de Valdecilla, Santander, Spain.
Victoria Sánchez-HellínMicrobiology Department, Hospital General Universitario de Elche, Elche, Spain.
Jordi VilaDepartment of Clinical Microbiology, Hospital Clínic, School of Medicine, University of Barcelona, Barcelona, Spain.
Barcelona Institute for Global Health · ESComplejo Hospitalario de Jaén · ESComplejo Hospitalario Universitario de Santiago · ESHospital General Universitario de Elche · ESHospital Universitari Arnau de Vilanova · ESHospital Universitario Príncipe de Asturias · ESHospital Universitario Puerta de Hierro Majadahonda · ESHospital Universitario Ramón y Cajal · ESInstituto Maimónides de Investigación Biomédica de Córdoba · ESMarqués de Valdecilla University Hospital · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Rapid diagnosis is one of the best ways to improve patient management and prognosis as well as to combat the development of bacterial resistance. The aim of this study was to study parameters that impact the achievement of reliable identification using a combination of flow cytometry and matrix-assisted laser desorption ionization time-of-flight mass spectrometry (MALDI-ToF-MS).The study was carried out in nine hospitals in Spain and included 1,050 urine samples with bacterial counts of 5x106 bacteria/ml. MALDI-ToF-MS-based identification was performed according to a previously described protocol. Valid identification by direct MALDI-ToF-MS was obtained in 72.8% of samples, in 80.3% of samples found to be positive by culture, 32.2% of contaminated samples, and 19.7% of negative samples. Among the positives samples with a valid identification the concordance at the species level was 97.2%. The parameters related to success of direct identification were: high bacterial count, the presence of Escherichia coli as a pathogen and rod-bacteria morphology provided by flow cytometry. The parameters related to failure were a high epithelial cell (EC) count, a high white blood cell (WBC) count and urine samples obtained from in-patients. In summary, this multicentre study confirms previously published data on the usefulness and accuracy of direct MALDI-ToF-MS-based identification of bacteria from urine samples. It seems important to evaluate not only the bacterial count, but also other parameters, such as EC and WBC counts, bacterial species and morphology, and the health care setting, to decide whether the sample is suitable for direct identification.

Indexed as

AdultAgedAged, 80 and overBacteriological TechniquesBacteriuriaEscherichia coli InfectionsFemaleFlow CytometryHumansMaleMiddle AgedReproducibility of ResultsSpainSpectrometry, Mass, Matrix-Assisted Laser Desorption-IonizationUrinary Tract InfectionsUrine

Identifiers

PMID30533050
PMCPMC6289437
OpenAlexW2904256659

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.